| Date | Time | Source | Announcement |
|---|---|---|---|
| 22 Nov 2002 | 07:00 AM | Purchase of Own Securities | |
| 21 Nov 2002 | 07:00 AM | Purchase of Own Securities | |
| 18 Nov 2002 | 07:00 AM | Purchase of Own Securities | |
| 15 Nov 2002 | 07:00 AM | Purchase of Own Securities | |
| 14 Nov 2002 | 03:00 PM | Directorate Change | |
| 14 Nov 2002 | 07:00 AM | Purchase of Own Securities | |
| 13 Nov 2002 | 07:00 AM | Purchase of Own Securities | |
| 11 Nov 2002 | 07:00 AM | Purchase of Own Securities | |
| 07 Nov 2002 | 08:30 AM | Annual Review | |
| 07 Nov 2002 | 07:00 AM | Crestor | |
| 05 Nov 2002 | 01:00 PM | Omeprazole Judgment Appeal | |
| 28 Oct 2002 | 07:00 AM | Exanta Express | |
| 24 Oct 2002 | 11:00 AM | 3rd Quarter Results-Part 2 | |
| 24 Oct 2002 | 11:00 AM | 3rd Quarter Results-Part 1 | |
| 23 Oct 2002 | 09:00 AM | Notice of Results | |
| 22 Oct 2002 | 11:49 AM | Omeprazole Patent Ruling | |
| 14 Oct 2002 | 07:06 AM | Prilosec Patents Ruling | |
| 30 Sep 2002 | 04:00 PM | Holding(s) in Company | |
| 25 Sep 2002 | 07:01 AM | Iressa | |
| 16 Sep 2002 | 07:00 AM | Symbicort | |
| 12 Sep 2002 | 07:00 AM | Purchase of Own Securities | |
| 11 Sep 2002 | 03:00 PM | Capital Group | |
| 11 Sep 2002 | 07:00 AM | Purchase of Own Securities | |
| 10 Sep 2002 | 07:00 AM | Purchase of Own Securities | |
| 06 Sep 2002 | 07:00 AM | Arimidex | |
| 06 Sep 2002 | 07:00 AM | Purchase of Own Securities | |
| 05 Sep 2002 | 07:00 AM | Purchase of Own Securities | |
| 04 Sep 2002 | 07:00 AM | Purchase of Own Securities | |
| 02 Sep 2002 | 07:00 AM | Purchase of Own Securities | |
| 02 Sep 2002 | 07:00 AM | Crestor Data | |
| 30 Aug 2002 | 07:00 AM | Purchase of Own Securities | |
| 22 Aug 2002 | 07:00 AM | Purchase of Own Securities | |
| 21 Aug 2002 | 07:00 AM | Purchase of Own Securities | |
| 19 Aug 2002 | 11:30 AM | Iressa Announcement | |
| 15 Aug 2002 | 07:00 AM | Purchase of Own Securities | |
| 14 Aug 2002 | 07:00 AM | Purchase of Own Securities | |
| 12 Aug 2002 | 07:00 AM | Purchase of Own Securities | |
| 09 Aug 2002 | 07:00 AM | Purchase of Own Securities | |
| 08 Aug 2002 | 07:00 AM | Purchase of Own Securities | |
| 07 Aug 2002 | 01:00 PM | Iressa | |
| 06 Aug 2002 | 02:00 PM | Update on Crestor | |
| 25 Jul 2002 | 11:00 AM | Interim Results - Part 2 | |
| 25 Jul 2002 | 11:00 AM | Interim Results - Part 1 | |
| 24 Jul 2002 | 09:00 AM | Notice of Results | |
| 05 Jul 2002 | 07:13 AM | Iressa In Japan | |
| 28 Jun 2002 | 07:00 AM | Purchase of Own Securities | |
| 27 Jun 2002 | 07:00 AM | Purchase of Own Securities | |
| 26 Jun 2002 | 07:00 AM | Purchase of Own Securities | |
| 25 Jun 2002 | 07:00 AM | Purchase of Own Securities | |
| 24 Jun 2002 | 07:00 AM | Purchase of Own Securities |
AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.
It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.
Astra Zeneca share price launched at 605p in 1993.